BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8655993)

  • 1. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection.
    Raboud JM; Montaner JS; Conway B; Haley L; Sherlock C; O'Shaughnessy MV; Schechter MT
    J Infect Dis; 1996 Jul; 174(1):191-4. PubMed ID: 8655993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
    Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
    Fiscus SA; Hughes MD; Lathey JL; Pi T; Jackson B; Rasheed S; Elbeik T; Reichman R; Japour A; Byington R; Scott W; Griffith BP; Katzenstein DA; Hammer SM
    J Infect Dis; 1998 Mar; 177(3):625-33. PubMed ID: 9498441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal and short-term stability of HIV virus load as measured by gene amplification.
    Holodniy M; Mole L; Winters M; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):363-8. PubMed ID: 7907661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays.
    Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F
    New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
    Bush CE; Donovan RM; Manzor O; Baxa D; Moore E; Cohen F; Saravolatz LD
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):11-5. PubMed ID: 8825613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen.
    Morand-Joubert L; Bludau H; Lerable J; Petit JC; Lefrère JJ
    J Med Virol; 1995 Sep; 47(1):87-91. PubMed ID: 8551265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.
    Prado JG; Shintani A; Bofill M; Clotet B; Ruiz L; Martinez-Picado J
    J Clin Microbiol; 2004 Apr; 42(4):1620-5. PubMed ID: 15071015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Read JS; Rich KC; Korelitz JJ; Mofenson LM; Harris R; Moye JH; Meyer WA; Pahwa SG; Bethel JW; Nugent RP
    Pediatr Infect Dis J; 2000 Jun; 19(6):544-51. PubMed ID: 10877171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
    JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study Group.
    Brown AE; Vahey MT; Zhou SY; Chung RC; Ruiz NM; Hofheinz D; Lane JR; Mayers DL
    J Infect Dis; 1995 Oct; 172(4):1091-5. PubMed ID: 7561186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
    J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
    Ledergerber B; Flepp M; Böni J; Tomasik Z; Cone RW; Lüthy R; Schüpbach J
    J Infect Dis; 2000 Apr; 181(4):1280-8. PubMed ID: 10751136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.
    Kovacs JA; Vogel S; Albert JM; Falloon J; Davey RT; Walker RE; Polis MA; Spooner K; Metcalf JA; Baseler M; Fyfe G; Lane HC
    N Engl J Med; 1996 Oct; 335(18):1350-6. PubMed ID: 8857018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.
    Schüpbach J; Böni J; Bisset LR; Tomasik Z; Fischer M; Günthard HF; Ledergerber B; Opravil M;
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):292-9. PubMed ID: 12843739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.
    Lathey JL; Hughes MD; Fiscus SA; Pi T; Jackson JB; Rasheed S; Elbeik T; Reichman R; Japour A; D'Aquila RT; Scott W; Griffith BP; Hammer SM; Katzenstein DA
    J Infect Dis; 1998 Mar; 177(3):617-24. PubMed ID: 9498440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.
    Henrard DR; Wu S; Phillips J; Wiesner D; Phair J
    J Clin Microbiol; 1995 Jan; 33(1):72-5. PubMed ID: 7699069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.